In a world where healthcare can feel impersonal, ANU researchers are making medical diagnoses at a genetic level and tailoring treatments to individuals like never before.

Herpes Simplex Virus (HSV) is a complex pathogen with far-reaching impacts. Over the course of five years, researchers Navneet and Sherin have made significant strides in understanding the virus, shedding light on its intricacies and paving the way for potential advancements in treatment.

Defects in the cellular protein factories can cause rare disorders known as ribosomopathies. A team led by Dr Amee George looks to find therapeutic targets through unravelling the molecular mechanisms underlying the diseases.